Latest News
Falcon Oil & Gas (FOG) Shares Surged 8% After Resuming Operations at Kyalla Well
Shares of Falcon Oil & Gas Ltd (LON: FOG) rallied 8% after resuming operations at its Kyalla 117 N2-1H ST2 well located in the Beetaloo Sub-Basin within the Northern Territory of Australia. The well is operated in conjunction with Falcon Oil’s
Oracle (ORCL) Stock Price Targets Raised By Analysts Following Earnings Report
Oracle (NYSE: ORCL) reported its fiscal first-quarter earnings on Monday, falling short on revenue. The software firm reported its earnings per share at $1.03, above the
Tern Shares Plunged 10.5% as Profits Elude the IoT Investment Firm During H1 2021
Shares of Tern PLC (LON: TERN) plunged 10.5% after releasing its interim half-year results, where it reported significant progress in its portfolio firm but no profits as yet. The investment company achieved significant milestones, including a 75%
Plug Power Announces European Expansion With German Headquarters
On Tuesday, hydrogen fuel cell company Plug Power (NASDAQ: PLUG) announced that it is expanding its operations with a European headquarters in North Rhine-Westphalia in Germany.
NRx Pharmaceuticals (NRXP) Stock Rallies On IQVIA (IQV) Collaboration
NRx Pharmaceuticals (NASDAQ: NRXP) shares have jumped premarket after the announcement of a collaboration with IQVIA (NYSE: IQV). The collaboration will see IQVIA provide pharmacovigilance services and medical information in preparation for potent
Ceres Power Shares Plunged 7.1% as Investor Sentiment Shifts to Negative
Shares of Ceres Power Holdings plc (LON: CWR) plunged 7.1% despite the hydrogen energy company not making any new announcements today. The hydrogen power company’s shares have been falling recently despite unveiling its 10kW solid oxide fuel cell
Could GameStop Shares Rally Back Above $350, and Should GameStop Invest in NFTs?
Shares of GameStop Corp. (NYSE: GME) were trading at $195 today as investors digested the company’s latest earnings results amid rumours of a looming partnership with fellow meme stock, AMC Entertainment. AMC had hinted at a possible partnership b
Panthera Resources Shares Rally After Announcing “Excellent” Gold Mineralisation at Labola Project
AIM-listed Panthera Resources (LON: PAT) has seen its share price rise on Tuesday after announcing assay results for the exploration drilling programme at the Labola project in Burkina Faso by its associate Moydow Holdings. The Labola project is o
Powerhouse Energy (PHE) Shares Gain As Partner Raises £2.2m
Powerhouse Energy (LON: PHE) shares are gaining after the hydrogen technology firm said its partner Hydrogen Utopia International (HUI), closed a fundraise on 9 September of £2.2 million.
Kanabo Share Price Climbs After Materia Receives Commercial Production Licence for Malta Facility
Medical cannabis R&D firm Kanabo Group (LON: KNB) said on Tuesday that Materia's subsidiary, Materia Malta Operating, has received a licence to produce cannabis for medicinal and research purposes from the Malta Medicines Authority. In July th
Power Metal Resources Shares Rally After Large Scale Gold Anomaly Confirmed
Shares of Power Metal Resources (LON: POW) are rallying on Tuesday after the company announced a large-scale gold-in-soil anomaly at the Tati project located in the Tati Greenstone Belt near Francistown, Botswana.
Valneva Shares Crash 42.8% After the UK Cancels COVID-19 Vaccines Order Worth €1.4Bn
Shares of Valneva SE (EPA: VLA) crashed 42.8% after the UK government cancelled its order for 100 million doses of the late-stage COVID-19 vaccine developed by the French company. The company’s COVID-19 vaccine is different from those already on t
Union Jack Oil (UJO) Shares Rose 7.74% on H1 Report, Progress at Wressle
Shares of Union Jack Oil PLC (LON: UJO) rose 7.74% after releasing its half-year unaudited results, highlighting the progress made at its Wressle oil project, which generated significant revenues for the company during test production. Wressle gen
Horizonte Minerals (HZM) Shares Rallied 8.5% After Securing $146.2M Araguaia Funding
Shares of Horizonte Minerals Plc (LON: HZM) rallied 8.5% after securing $146.2 million credit approvals from two export credit agencies (ECAs) for its Araguaia nickel project in Brazil. Today’s announcement marks a significant win for the company
Nuformix Shares Surged 19.3% on Exclusive Cancer Drug Licensing Deal With Oxilio
Shares of Nuformix PLC (LON: NFX) surged 19.3% after signing an exclusive licensing deal with Oxilio Ltd to develop and commercialise its NXP001 cancer drug candidate. According to the agreement, Oxilio will develop, research and market NXP001 wor
Genedrive (GDR) Shares Plunge After Announcing Placing and Open Offer To Raise Over £10m
Shares of Genedrive (LON: GDR) have plunged on Friday after the company announced a placing to raise up to £6 million and an open offer to qualifying shareholders to raise up to £4.5 million. The company will be placing up to 24 million new shares
Audioboom Shares Fell 6.82% After AAA Fails To Submit Revised Offer, Looming Deadline
Shares of Audioboom Group PLC (LON: BOOM) plunged 6.82% after an update indicating that All Active Asset Management (AAA) had not submitted a revised offer to acquire the company after its £188.3 million offer was rejected for having a low valuation.
Clinigen Shares Surged 9.94% on Rumours That It Could Be an Acquisition Target
Shares of Clinigen Group PLC (LON: CLIN) surged 9.94% on rumours that it could be the next acquisition target for Elliott Investment Management LP, which recently acquired a 5% stake in the company. The specialist pharmaceutical services company r
Gresham House Shares Edge Higher After Acquiring Mobeus Equity’s VC Division
Shares of Gresham House plc (LON: GHE) edged 1.34% higher after acquiring Mobeus Equity Partners’ Venture Capital Trust (VCT) business. The transaction will cost £36.1 million, with Gresham intending to fund the purchase via a £40 million share pl
IQ-AI Shares Fell 2.6% After Postponing Phase I Clinical Trial for Brain Tumour Drug
Shares of IQ-AI Ltd (LON: IQAI) fell 2.6% after postponing the start of its Gallium Maltolate phase I clinical trial to the fourth quarter due to a delay in the production and delivery of the drug’s encapsulation by the supplier. The trial was sch